ARCHIVES

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

This article is from The Cancer Letter archive.

Vol. 11 No. 12 | March 22, 1985

Download PDF Visit The Full Archive

Related Articles

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Community Centers Group Lines Up A Speaker

January 10, 1975

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999